Information about Chan Zuckerberg Initiative (CZI) Science can be found at
https://chanzuckerberg.com/science
In particular, under "Our Approach to Supporting Projects", there is context about the CZI perspective on Open Science
https://chanzuckerberg.com/science#Approach
- Intellectual Property Should we build an IP portfolio, or should IP be generated by a CZI-supported investigator or research project, our policy is that the IP should be made freely available for academic and noncommercial use. Where IP is developed together with other organizations, we will promote non-exclusive licensing of technologies so that they have the broadest reach and impact.
- Data sharing and software We are deeply committed to developing and using platforms that disseminate data openly and freely. We are also committed to releasing software under maximally permissive open-source licenses, and developing software collaboratively in the open through sites like GitHub. We are committed to the long-term sustainability of our projects – when needed, we will explore alternative ways to ensure data access through permanent archives. Also when needed, we will work with regulatory groups to ensure that data requiring protection or controlled access are handled in a controlled and proper way in agreement with national and international standards.
- Publication We support full publication without conditions or restrictions on academic and publication freedom. We strongly encourage, and in some cases, may require, researchers to deposit manuscripts as preprints before peer review to increase access to research findings and to communicate results more quickly.
There is some additional text in the RFA for the Neurodegeneration Challenge Network, in the Collaboration and Open Science section
CZI supports open science values and principles. To accelerate scientific discovery and collaboration and rapid dissemination, CZI supports a consent, sharing, and publication policy for open and rapid dissemination of research results and a policy for software development that maximizes accessibility, reuse, and shared development.
You can also watch Dr. Cori Bargmann, the President of Chan Zuckerberg Science, present a 2018 AAAS plenary entitled Accelerating Biomedical Research
http://players.brightcove.net/53038991001/Byx2STOH0_default/index.html?videoId=5736045412001
Previously:
April 25, 2017 Chan Zuckerberg - Meta and preprints
Comments